Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.63% |
| 2 | Technology | 13.19% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Financials | 8.74% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
1676
DELISTED
Calithera Biosciences, Inc
CALA
| $6.87M | 0.01% |
60,151
+6,211
| +12% | +$467K |
|
|
GV
1677
DELISTED
Goldfield Corporation
GV
| $6.87M | 0.01% |
1,933,998
+58,668
| +3% | +$152K |
|
|
GEN
1678
DELISTED
Genesis Healthcare, Inc.
GEN
| $6.83M | 0.01% |
4,167,285
+245,755
| +6% | +$369K |
|
1679
Customers Bancorp
CUBI
$2.82B
| $6.82M | 0.01% |
286,409
+261,589
| +1,054% | +$6.01M |
|
1680
Select Water Solutions
WTTR
$2.69B
| $6.81M | 0.01% |
733,742
+280,657
| +62% | +$2.27M |
|
1681
Forward Air
FWRD
$640M
| $6.78M | 0.01% |
96,939
+66,500
| +218% | +$4.51M |
|
1682
Dick's Sporting Goods
DKS
$18.1B
| $6.78M | 0.01% |
+137,000
| New | +$5.83M |
|
1683
Eastern Company
EML
$153M
| $6.72M | 0.01% |
220,200
+2,390
| +1% | +$66.9K |
|
1684
GSI Technology
GSIT
$270M
| $6.72M | 0.01% |
947,447
+32,600
| +4% | +$247K |
|
1685
Equity Bancshares
EQBK
$1.06B
| $6.7M | 0.01% |
216,900
-42,700
| -16% | -$1.22M |
|
|
CBD
1686
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $6.69M | 0.01% |
306,100
+34,100
| +13% | +$684K |
|
|
OPI
1687
DELISTED
Office Properties Income Trust
OPI
| $6.68M | 0.01% |
207,955
+192,800
| +1,272% | +$6.18M |
|
1688
HealthEquity
HQY
$8.76B
| $6.68M | 0.01% |
90,131
-857,812
| -90% | -$53.5M |
|
|
ECHO
1689
DELISTED
Echo Global Logistics, Inc.
ECHO
| $6.66M | 0.01% |
321,800
+127,500
| +66% | +$2.66M |
|
1690
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $6.62M | 0.01% |
+187,363
| New | +$6.6M |
|
1691
Dentsply Sirona
XRAY
$2.31B
| $6.61M | 0.01% |
116,758
-36,600
| -24% | -$2.04M |
|
1692
Lindsay Corp
LNN
$1.17B
| $6.58M | 0.01% |
68,587
-71,700
| -51% | -$6.55M |
|
|
SPNE
1693
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $6.56M | 0.01% |
546,314
+91,214
| +20% | +$1.11M |
|
|
PWOD
1694
DELISTED
Penns Woods Bancorp
PWOD
| $6.55M | 0.01% |
184,202
-2,001
| -1% | -$63.6K |
|
1695
Targa Resources
TRGP
$59.1B
| $6.52M | 0.01% |
+159,586
| New | +$6.19M |
|
1696
Tenable Holdings
TENB
$4.22B
| $6.51M | 0.01% |
271,900
+182,800
| +205% | +$4.45M |
|
1697
Orrstown Financial Services
ORRF
$852M
| $6.51M | 0.01% |
287,801
+27,724
| +11% | +$610K |
|
1698
H.B. Fuller
FUL
$3.38B
| $6.5M | 0.01% |
126,100
+67,500
| +115% | +$3.34M |
|
1699
SAP
SAP
$240B
| $6.5M | 0.01% |
+48,481
| New | +$6.37M |
|
1700
Gogo Inc
GOGO
$383M
| $6.49M | 0.01% |
1,013,900
+174,500
| +21% | +$1.02M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.